Enveric Biosciences, Inc. ENVB
Set alert
1.43 USD -0.03 -2.05%
At close · Oct 30
1.43 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.40 Day range 1.48
1.27 52-week range 10.33
- YTD
- -60.61%
- 1 year
- -76.67%
- Open
- 1.47
- Prev close
- 1.46
- Mkt cap
- 6.40M
- Vol
- 12.00K
- Avg vol
- 86.31K
- EPS
- -13.01
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.40
- High
- 1.48
- Forward P/E
- -0.22
- Beta
- 0.47
- Short ratio
- 0.31
- Inst. own
- 7.06%
- Dividend
- 0.00
- Ex-div date
- Apr 22, 2008
- 50-d avg
- 0.40876
- 200-d avg
- 0.63229
- 1y target
- 0.00
5D chart
Signals (22)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 12:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 10:45 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:45 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 9:45 AM | 2 days ago |
| MACD: Buy Signal | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:45 PM | 3 days ago |
| SMA: Bullish | Oct 27, 2:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:50 PM | 4 days ago |
| SMA: Bullish | Oct 27, 11:05 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 26, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 23, 3:55 PM | 1 week ago |
| SMA: Bearish | Oct 23, 3:50 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:45 PM | 1 week ago |
News
1 week ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Tempest Therapeutics (NASDAQ:TPST) stock rose 8.9% to $0.57 during Wednesday's after-market session. The market value of their outstanding shares is at $10.1 million. Tenax Therapeutics…
1 week ago benzinga.com
Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate
Enveric Biosciences posts positive preclinical data for EB-003, showing favorable absorption and safety for psychiatric therapies.